Brief: Chong Kun Dang Pharmaceutical Signed $1.3 Billion Technology Transfer Deal With Novartis
06/11/2023 03:15
Nov 6 (Reuters) - Chong Kun Dang Pharmaceutical Corp
185750.KS :
* SIGNED $1.3 BILLION TECHNOLOGY TRANSFER DEAL WITH NOVARTIS
Source text for Eikon: ID:
Further company coverage: 185750.KS
((ju-min.park@thomsonreuters.com;))
Recent news on Chong Kun Dang Pharmaceutical
See all newsBrief: Chong Kun Dang Pharmaceutical Q3 Operating Profit 23.7 Billion Won, Up 15.4% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical Corp To Invest 392.5 Billion Won In Research Centre And Other Facility
Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit 17.6 Billion Won, Up 37% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical Q3 Operating Profit 20.5 Billion Won, Down 19% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical To Divest 61 Billion Won Worth Of Own Shares